Shaman Pharmaceuticals Inc.

As of August 18, 2005, Shaman Pharmaceuticals, Inc. went out of business as per its Chapter 7 liquidation filing under bankruptcy. Shaman Pharmaceuticals Inc. engages in the discovery, development, and marketing of novel, proprietary botanical dietary supplements derived from tropical plant sources. The company also has the ability to out-license a pipeline of botanical product candidates, as well as novel pharmaceutical product candidates for major human diseases. Its botanical dietary supplement product is a Normal Stool Formula (NSF), which is designed to relieve diarrhea without causing constipation. NSF is an extract of Croton lechleri, a plant used by indigenous people for relief of gastrointestinal symptoms; and contains a chemical activity marker, SP-303, a patented, anti-diarrhea agent. Shaman has developed a trademarked Syndrome X diet system for persons exhibiting Syndrome X symptoms. Its consumers include primarily in the HIV/AIDS community, the traveler's market, and Syndrome X community; and mass market companies that are interested in licensing or partnering with the company for the commercialization of its products. The company is based in South San Francisco, California.